Company Overview
| Stock Name | 新世紀醫療控股有限公司 |
|---|---|
| Stock Code | 01518 |
| Company Full Name | 新世紀醫療控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國從事提供兒科及婦產科專科服務，以及提供醫院諮詢服務。 |
| Listing Date | 2017-01-18 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市西城區南禮士路56號 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.ncich.com.cn |
| Share Registrar | |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 7.36 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 16.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 88,320,000 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 7.35 |
|---|---|
| First Day Open | HK$ 7.5 |
| First Day Change | -0.14% |
| First Day Volume | 12546500.0 |
| First Day Turnover | 91943300.0 |
Use of Proceeds
| Use of Proceeds | 1、39.4百萬港元（相當于所得款項凈額的5.0%）將用于在北京興建一座遠程醫療診斷中心； 2、39.4百萬港元（相當于所得款項凈額的5.0%）將用于翻新及提升我們于北京的一間手術中心； 3、157.7百萬港元（相當于所得款項凈額的20.0%）將用于在北京開設一家新醫院以提供專業兒科及婦產科服務以及在北京開設兩家診所以主要提供門診服務； 4、157.7百萬港元（相當于所得款項凈額的20.0%）將用于在北京以外的一線城市開設一間新醫院及兩間診所； 5、315.5百萬港元（相當于所得款項凈額的40.0%）將用于收購一線城市（包括北京）的一間醫院及五間診所； 6、78.9百萬港元（相當于所得款項凈額的10.0%）將用作營運資金及其他一般公司用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
Merrill Lynch (Asia Pacific) Limited CE AAC198
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
Merrill Lynch (Asia Pacific) Limited CE AAC198
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (4)
Merrill Lynch (Asia Pacific) Limited CE AAC198
中国国际金融香港证券有限公司 CE AEN894
中银国际亚洲有限公司 CE AET863
招商证券（香港）有限公司 CE AAI650
Joint Lead Managers (4)
Merrill Lynch (Asia Pacific) Limited CE AAC198
中国国际金融香港证券有限公司 CE AEN894
中银国际亚洲有限公司 CE AET863
招商证券（香港）有限公司 CE AAI650
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | CNCB (Cayman) NCH LP | 175,904,000 HKD | — | 4.98% | — | 6 months | 2017-07-18 |
| 2 | Janchor Partners Pan-Asian Master Fund | 155,093,600 HKD | — | 4.39% | — | 6 months | 2017-07-18 |
| 3 | 中国人寿再保险有限责任公司 | 232,642,240 HKD | — | 6.59% | — | 6 months | 2017-07-18 |
Directors & Management
| Chairman | Jason ZOU |
|---|---|
| Company Secretary | 賈曉鋒 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | Jason Zhou(44.40%);梁艷清(11.78%);天津泰鼎投資有限公司(6.47%);安怡和康(天津)投資合伙企業(有限合伙)(6.44%);中國再保險(集團)股份有限公司(6.42%) |
|---|
